A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 22, 2014

Primary Completion Date

March 27, 2015

Study Completion Date

October 21, 2016

Conditions
Advanced Solid TumorsRelapsed/Refractory Lymphoma
Interventions
DRUG

Alisertib

Alisertib tablets

DRUG

Itraconazole

Itraconazole oral solution

Trial Locations (4)

Unknown

St Louis

Oklahoma City

Germantown

Dallas

All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY